Pharmacotherapeutics (PHAR4811)


This unit of study will focus on developing students' understanding of the use of medicines and related appropriate health measures in special patient populations (e.g. paediatrics). The unit of study will draw upon concepts in clinical pharmacy, pharmacokinetics and clinical practice.
Through a series of workshops, students will undertake activities including case-study analysis, role-plays, problem solving and case presentations. These activities will help students explore information sources for drug use and integrate knowledge of clinical indices, laboratory data, medication use history and demographic information to optimise drug therapy in response to the needs of individual patients. Students will gain 'hands-on' practice in the provision of patient-specific medicine use education and explore key issues concerning the maintenance of vigilance for medicines use specific to certain population groups.

Our courses that offer this unit of study

Further unit of study information


32 x 1hr lectures, 8 x 3hr small group learning and up to 18hrs of self directed learning


Final exam (40%), group portfolios (20%), workshop participation (40%)


Standard Reference Texts for Medications (AMH, APF, eMIMS). In addition, current research articles provided via subject guides/library will inform the reference base for this Unit of Study.

Faculty/department permission required?


Unit of study rules

Prerequisites and assumed knowledge

PHAR3811 and PHAR3812 and PHAR3813 and PHAR3814 and PHAR3821 and PHAR3822 and PHAR3823 and PHAR3824


PHAR4812 and PHAR4814 and PHAR4823

Study this unit outside a degree

Non-award/non-degree study

If you wish to undertake one or more units of study (subjects) for your own interest but not towards a degree, you may enrol in single units as a non-award student.

Cross-institutional study

If you are from another Australian tertiary institution you may be permitted to underake cross-institutional study in one or more units of study at the University of Sydney.